Silence Therapeutics (SLN)
NASDAQ: SLN
· Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT
Silence Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -28.53M | 22.89M | -41.88M | -15.56M | -3.37M | -14.97M | -10.66M | -12.01M | -12.67M | -15.05M | -9.33M | -13.42M | -9.57M | -11.23M | -12.05M | -12.71M | -9.87M |
Depreciation & Amortization | 73K | 119.28K | 115K | 119K | 120K | 121K | 125K | 118K | 134K | 141K | 114K | 114K | 113K | 66K | 110K | 123K | 128K |
Stock-Based Compensation | 3.54M | 3.42M | 3.1M | 3.28M | 3.25M | 1.5M | 3.85M | 3M | 4.69M | 1.73M | 2.39M | 3.06M | 3.08M | 1.84M | 2.58M | 2.72M | 1.49M |
Other Working Capital | n/a | -24.23M | -1.14M | 3.98M | -4.36M | -1.37M | -8.19M | 4.08M | -6.49M | -4.46M | -799K | 3.09M | -5.51M | 6.62M | 546K | 35.14M | -3.46M |
Other Non-Cash Items | n/a | -24.97M | 18.76M | -2.83M | -791K | 1.67M | -2.04M | 553K | 7.46M | 5.02M | -4.55M | -785K | -236K | -36K | -232K | -219K | 529K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 940K | 179K | 312K | n/a | n/a | n/a | n/a | n/a | 531K | 4.12M | 977K | -908K |
Change in Working Capital | n/a | -26.32M | 253.54K | 10.18M | -15.68M | -1.13M | 3.67M | -6.93M | -7.27M | -5.24M | 1.97M | 2.76M | -7.76M | 6.62M | 546K | 35.14M | -3.46M |
Operating Cash Flow | -12.31M | -24.86M | -19.66M | -4.81M | -7.5M | -11.87M | -4.87M | -14.96M | -7.66M | -13.41M | -9.4M | -8.27M | -14.38M | -2.21M | -4.93M | 26.03M | -12.09M |
Capital Expenditures | -4K | -55.77K | -70.49K | -67K | n/a | -1K | -20K | 3K | -33K | -303K | -47K | -37K | -53K | -550K | -331K | -439K | -14K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -70.06M | -21.26M | -68.02M | n/a | -39.44M | n/a | -2K | -20.66M | n/a | n/a | n/a | n/a | n/a | 10M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 91.43M | 19.41M | n/a | n/a | n/a | 20.1M | 16.08M | n/a | n/a | n/a | -2K | 2K | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 25.68M | -1.98M | 19.82M | 615K | -39.03M | 383K | 546K | -20.79M | 161K | -16.11M | 5K | 4K | -51K | -5M | 5M | 3K | 1K |
Investing Cash Flow | -44.38M | 68.13M | -28.84M | 548K | -39.03M | 382K | 20.63M | -4.71M | 128K | -16.41M | -42K | -35K | -51K | 4.45M | 4.67M | -436K | -13K |
Debt Repayment | n/a | 49K | -49K | n/a | n/a | -43K | -49K | -34K | -48K | -78K | -15K | -50K | -47K | -1K | 406K | -502K | -114K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 14K | 9.38M | -935.04K | -97K | -6.54M | n/a | n/a | 3.22M | n/a | n/a | 43.08M | n/a | n/a | 29.9M | n/a | 440K | n/a |
Financial Cash Flow | 14K | -8.3M | 15.8M | 847K | 105.56M | 9.92M | 12.03M | 3.18M | 19K | 44K | 43.06M | -11K | -47K | 29.9M | 425K | -62K | 30.35M |
Net Cash Flow | -56.68M | 38.42M | -47.53M | -3.57M | 59.02M | -4.78M | 29.09M | -17.01M | -8.09M | -35.2M | 38.45M | -7.73M | -14.24M | 2.07M | 231K | 25.51M | 18.28M |
Free Cash Flow | -12.31M | -24.92M | -19.7M | -4.88M | -7.5M | -11.87M | -4.89M | -14.95M | -7.69M | -13.71M | -9.45M | -8.3M | -14.43M | -2.75M | -5.26M | 25.59M | -12.11M |